From Morphology to Gene Expression Profiling in Mycosis Fungoides: Is It Still a Diagnostic Challenge? [PDF]
Filosa A +6 more
europepmc +1 more source
AFED, a comprehensive resource for Aspergillus flavus gene expression profiling. [PDF]
Mack BM, Lebar MD.
europepmc +1 more source
A computational framework for optimizing mRNA vaccine delivery via AI-guided nanoparticle design and <i>in silico</i> gene expression profiling. [PDF]
Di Salvatore V +3 more
europepmc +1 more source
Gene expression profiling of KLF4 and KLF5 in visceral adipose tissue of obese women: insights into adipogenic and metabolic regulation. [PDF]
Muhi DJ +5 more
europepmc +1 more source
Gene expression profiling in pure neural leprosy: insights into pathogenesis and diagnostic biomarkers. [PDF]
de Athaide MM +8 more
europepmc +1 more source
Gene expression profiling for the diagnosis of male breast cancer. [PDF]
Liu J +8 more
europepmc +1 more source
Related searches:
Gene expression profiling of porokeratosis
Journal of Cutaneous Pathology, 2008Background: Porokeratosis (PK) represents a heterogeneous group of disorders of keratinization and has a wide variety of clinical manifestations. PK may exhibit similarities with psoriasis at both clinical and molecular levels. The genetic basis and pathogenesis for PK remain elusive.Methods: We studied the transcriptional profiles of three pairwise ...
Zheng-Hua, Zhang +11 more
openaire +2 more sources
Gene Expression Profiling in Ecotoxicology
Ecotoxicology, 2003Gene expression profiling is a powerful new end point for ecotoxicology and a means for bringing the genomics revolution to this field. We review the usefulness of gene expression profiling as an end point in ecotoxicology and describe methods for applying this approach to non-model organisms.
Terry W, Snell +2 more
openaire +2 more sources
Gene expression profiling in sarcomas
Critical Reviews in Oncology/Hematology, 2007Sarcomas are a heterogeneous group of malignant mesenchymal tumors of difficult classification. There is considerable variability in both histological appearance and responsiveness to therapy. Their overall poor clinical prognosis is reflected by the fact that >65% of patients suffering retroperitoneal soft tissue sarcoma die within 5 years [Heslin MJ,
Katharina, Tschoep +4 more
openaire +2 more sources

